The capability of KIR-ESS to inhibit tumor growth correlated with its efficacy in reducing levels of pY-STAT3 within the tumors, particularly in those areas surrounding tumor mass likely enriched of keratinocytes responsible for maintaining tumor growth [34]. This evidence concerns the gene STAT3 and neoplasm.